November 25, 2014
Novartis AG on Monday ducked a putative class action alleging it broke New Jersey consumer fraud laws by charging more for a migraine medicine than for another chemically identical painkiller when a federal judge ruled that, while strategic, the company's pricing scheme wasn't illegal.
January 02, 2014
Novartis AG was hit with a proposed consumer class action in New Jersey federal court Tuesday claiming the Swiss pharmaceutical giant sells a popular over-the-counter migraine medication at a higher price than an identical product marketed under a different name.